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Abstract: Dietary changes affect the composition and structure of gut microbiota (GM) in animals
and humans. One of the beneficial effects of consuming products derived from plants is the positive
influence on immunity and gastrointestinal health. Species belonging to the genus Allium contain
many organosulfur compounds (OSCs) that have been widely studied showing their biological
properties and beneficial effects on intestinal health and GM. This is the first systematic review of
OSCs from Allium performed following the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines, and it is based on the evidence that we found in literature about
the benefits on the GM and intestinal health demonstrated by OSCs from Allium, and specifically
from onion. OSCs from Allium cepa have shown a significant antibacterial activity against a broad
spectrum of antibiotic-resistant Gram-positive and Gram-negative bacteria. In addition, the intake of
OSCs from onion was able to modulate the composition of GM, increasing the beneficial bacterial
populations in animal models. Moreover, the beneficial effects observed in murine models of colitis
suggest that these compounds could be suitable candidates for the treatment of inflammatory bowel
disease (IBD) or reverse the dysbiosis caused by a high-fat diet (HFD). Despite the evidence found
both in vitro and in vivo, we have not found any article that tested OSCs different from allicin in
clinical trials or dietary intervention studies in humans. In this sense, it would be interesting to
conduct new research that tests the benefits of these compounds in human GM.
Keywords: Allium cepa; dysbiosis; gut microbiota (GM); intestinal health; organosulfur compounds
(OSCs); thiosulphonates
1. Introduction
From the moment of their birth, humans are already colonised by microorganisms in
the gastrointestinal tract (GT), oral cavity, vagina or skin. Gut microbiota (GM) includes the
set of bacteria that colonise the GT and maintains the integrity of epithelium, establishing
a physical barrier against pathogens. In addition, to ease digestion and absorption of
nutrients, the GM helps metabolism by synthesis of essential nutrients [1] and also stim-
ulates the production of antimicrobial compounds in the host. In recent years, plenty of
assays have demonstrated that enteric bacteria play a fundamental role in aspects of human
health such as the promotion of adaptive immunity, cognition pathologies, inflammatory
bowel disease (IBD), metabolic syndrome or colorectal cancer [2–8]. Even host emotions
and behaviour have been associated with changes in the ecology of their GM [9,10]. In
fact, the gut microbiome is currently considered as an independent organ that shows both
physiological and pathological effects [11,12].
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The composition and development of the newborn’s GM are influenced by several
aspects, including sex, the gestational age or drug use during the perinatal period [13].
Throughout the life of the individual, the symbiotic relationship of GM with the host
can be commensal or mutualistic, including a range of factors affecting the composition
of GM. There is evidence on the possible coevolution of the host and its autochthonous
microbiota since this symbiotic association between host and microbiome could have
played an important role in the process of human evolution [14,15]. The GM of mammals
encompasses more than 100 billion microorganisms, including bacteria, eukaryotes cells
such as certain fungi, archaeas and viruses. More than 90% of the bacteria in GM belong
to the phylums Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Fusobacteria and
Verrucomicrobia, being the two most abundant Firmicutes (F) and Bacteroidetes (B). Most
of the beneficial bacteria present in GM, such as Lactobacillus and Bifidobacterium, are
included in Firmicutes phylum [10,16]. Imbalances in the composition of GM, also known
as dysbiosis, can be caused by DNA mutations, antibiotic therapy, inflammatory processes
or the lifestyle, in particular, due to unhealthy eating habits and sedentary behaviours.
During dysbiosis, some genera or species of potentially harmful bacteria increase in the
GM, leading to a disease-prone condition, such as respiratory, cardiovascular, neurological
or gastroenterological disorders [1,17,18]. For instance, obese people have a higher F/B
ratio compared to people with normal weight, which implies that also obesity could also
be related to changes in GM [19].
According to previous studies conducted in both humans and animals, changes in
GM can occur rapidly, even within a few hours. These changes alter the functions of
microorganisms and are usually characterized by a decrease in diversity and a higher
F/B ratio [15], which may lead to chronic metabolic diseases. A well-studied case is the
relationship between GM of newborns and gestational diabetes mellitus [20]. Other clinical
and preclinical studies have shown that the presence of some bacteria belonging to the
Proteobacteria phylum, such as Escherichia coli, Helicobacter pylori and Salmonella enterica, can
be associated with colon inflammation and colorectal cancer [1]. On the contrary, there
is evidence that the depletion of some species in GM, such as Faecalibacterium prausnitzii,
might be related to the development of IBD [21].
Both the standard nutrient intake and severe dietary changes affect the composition
and structure of GM. Diet-induced dysbiosis is a contributing factor to the development of
diseases such as allergy, type 2 diabetes, cardiovascular disorders, IBD, Crohn’s disease,
ulcerative colitis, irritable bowel syndrome, nonalcoholic fatty liver disease and colorectal
cancer [3,22–28]. However, as recent studies suggest, nutritional interventions can also
modify the composition of GM in a positive manner, reducing the development of patholo-
gies associated with inflammation such as intestinal diseases, rheumatoid arthritis, asthma
and acne [29–31]. Short-term dietary interventions in healthy humans produce rapid and
statistically significant alterations in the composition of GM, although their effects are less
relevant in terms of species variability [32].
Dietary strategies conducted with prebiotics and probiotics are able to modulate the
composition and functionality of the human GM [33]. Other dietary habits, such as high
consumption of fruits and vegetables, can also significantly improve the biodiversity of
GM because of their high content in bioactive phytochemicals [11,34]. Phytochemicals
are natural compounds produced by plants to help them to resist fungi, bacteria and
plant virus infections and also to avoid their consumption by insects or other animals [35].
The most common found in foods are polyphenols, carotenoids, phytosterols, alkaloids,
glucosinolates, terpenes and organosulfur compounds (OSCs) [36]. As shown in Figure 1,
phytochemicals may also affect the composition and structure of GM, and consequently
impact the host metabolism, inflammatory response or development of infections.




Figure 1. Interactions between host and gut microbiota. Phytochemicals influence the intestinal 
microbiota, which establishes mutual interactions and interdependencies with the host. 
The GM plays a key role in the general health condition, having a symbiotic relation-
ship with the host with a direct influence on numerous diseases [29,37] (Figure 1). The 
immune system influences the proliferation and colonisation of certain microorganisms 
in intestinal microbiota through the production of immunoglobulins or cytokines [38]. In 
addition, GM regulates host metabolism, immunity and stimulation of the central nervous 
system [39,40]. The microorganisms of GM transform the components of the food ingested 
through fermentative processes, producing metabolites that can be beneficial or harmful 
[18]. These metabolites, in combination with other compounds present in food, modulate 
the host’s immune system. Reciprocally, some components of the diet can modulate the 
composition and functional capacity of GM, inducing the growth of probiotic bacteria [41]. 
In this way, diet can severely influence immunity and the progress of a possible host in-
fection, altering the diversity, abundance and functions of GM [11,42] (Figure 1). 
In recent literature, it can be found how prebiotics, probiotics or phytochemicals in-
fluence various pathologies, thus achieving an important therapeutic strategy for the pre-
vention and treatment of human diseases [43,44]. In particular, dietary fibre and phyto-
chemicals can change the composition of GM, inhibiting the growth of pathogens and 
increasing the population of beneficial bacteria. These bacteria produce some metabolites, 
such as short-chain fatty acids, which further modify the intestinal environment, improv-
ing glycaemic control, lipid profile and inflammation [15,45]. Phytochemicals have been 
shown to be capable of modulating GM in a few days after their inclusion in carefully 
controlled diets [1,35]. Although several studies have reported phytochemical-induced 
GM alterations, much remains to be investigated on the molecular mechanisms and inter-
actions between the gut bacteria involved [35,46]. However, some clinically controlled di-
etary interventions have studied the effect of these compounds on the human GM, show-
ing a positive influence on the health of the study subjects [17]. Although the most studied 
phytochemicals are polyphenols, other plant-derived compounds, such as OSCs from Al-
lium vegetables, have also shown a significant potential effect to modify the composition 
of bacterial communities [47–50]. 
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can modulate the composition and functional capacity of GM, inducing the growth of
probiotic bacteria [41]. In this way, diet can severely influence immunity and the progress
of a possible host infection, altering the diversity, abundance and functions of GM [11,42]
(Figure 1).
In recent literature, it can be found how prebiotics, probiotics or phytochemicals
influence various pathologies, thus achieving an important therapeutic strategy for the
prevention and treatment of human diseases [43,44]. In particular, dietary fibre and phy-
tochemicals can change the composition of GM, inhibiting the growth of pathogens and
increasing the population of beneficial bacteria. These bacteria produce some metabolites,
such as short-chain fatty acids, which further modify the intestinal environment, improv-
ing glycaemic control, lipid profile and inflammation [15,45]. Phytochemicals have been
shown to be capable of modulating GM in a few days after their inclusion in carefully
controlled diets [1,35]. Although several studies have reported phytochemical-induced GM
alterations, much remains to be investigated on the molecular mechanisms and interactions
between the gut bacteria involved [35,46]. However, some clinically controlled dietary
interventions have studied the effect of these compounds on the human GM, showing
a positive influence on the health of the study subjects [17]. Although the most studied
phytochemicals are polyphenols, other plant-derived compounds, such as OSCs from
Allium vegetables, have also shown a significant potential effect to modify the composition
of bacterial communities [47–50].
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The genus Allium includes more than 900 species of plants, being the most studied
species Allium sativum (garlic), Allium cepa (onion), Allium ampeloprasum var. porrum (leek)
and Allium ascalonicum (shallot). The therapeutic properties of these plants are widely
known since time immemorial [47,48,51]. OSCs are the most important class of bioactive
compounds in Alliaceae, which are synthesized during tissue damage in Allium as part
of the defence mechanism against foreign aggressions. OSCs confer biological properties
that are beneficial for health, such as antibacterial, antifungal, antiviral, antiprotozoal,
anti-inflammatory, antidiabetic, antioxidant, antimutagenic, hepatoprotective or neuro-
protective activities, among others [52–58]. The main OSCs in the genus Allium include
the precursors S-alk(en)yl-L-cysteine sulphoxides (ACSO), whose transformation leads to
thiosulfinates, thiosulfonates and sulfides in variable amounts and types. The characteristic
pungent aroma of each Allium species is associated with the different levels of ACSO
precursors they contain, which are primarily transformed into thiosulfinate compounds.
When Allium bulbs are crushed, an enzyme called alliinase, common to all Allium species,
is released from the vacuoles of cells and catalyses the cleavage of ACSO into sulfenic acid
intermediates [59]. These intermediates are highly reactive and produce thiosulfinates, as
shown in Figure 2.
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Once the number of studies included for this systematic review was obtained, their quality 
assessment started. It consisted of an assessment of the risks of bias of each of the studies, 
following the model published in previous studies [10,13]. 
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Nevertheless, thi sulfinates are also highly reactive molecules and, under certain
conditions, can decompose to form other sulfur compounds, including symmetric or
asymmetric thiosulfonates and sulfides [56,57]. Depending on the Allium species, the
pathways for the transformation of thiosulfinates and the derivatives formed may differ.
In the case of garlic, alliin (S-allyl-L-cysteine sulfoxide) is the most important precursor.
It is distributed into the cellular cytoplasm and, when the garlic is chopped or crushed,
the contact of alliin and alliinase produces allyl sulfenic acid and dihydroalanine. Two
molecules of allyl sulfenic acid are condensed, forming allicin (diallyl thiosulfinate), which
is the most important OSC of the genus [56,57]. However, allicin is extremely unstable
and, at room temperature, is rapidly transformed by different mechanisms in other com-
pounds such as ajoene, dithiins or diallyl disulfide. In onion, the most common sulfur
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compounds are isoalliin (S-propenyl-L-cysteine sulfoxide) that changes into lachrymatory
factor (Z-propanethial S-oxide); methiin (S-methyl-L-cysteine sulfoxide), also found to be
present in garlic; and propiin (S-propyl-L-cysteine sulfoxide) that, due to the action of
alliinase, leads to dipropyl thiosulfinate (PTS) [60]. Although PTS is more stable than al-
licin, it is also a labile compound that, as happens with other thiosulfinates, is transformed
into dipropyl disulfide and propyl-propane thiosulfonate (PTSO) through dismutation or
disproportionation reactions [56] (Figure 2).
Although numerous studies on the effects of allicin in human GM have been carried
out, no articles have been found explaining their effects considering biological active
OSCs derived from Allium, as thiosulfonates. Therefore, this is the first systematic review
considering the benefits on the GM and intestinal health demonstrated by OSCs from
Allium, and specifically from onion.
2. Materials and Methods
The design of the present systematic review followed the PRISMA 2020 guidelines [61].
The eligibility criteria were: Inclusion criteria: (1) works that relate the effect of OSCs from
onion on GM; (2) articles published from inception to 14 March 2021; and (3) articles
reporting comprehensive results and/or information on GM and OSCs. Exclusion criteria:
(1) unsystematic narrative reviews; (2) works published in a language other than English;
(3) dissertations and proceedings of conferences; (4) books and book chapters; (5) editorial
material; (6) articles dealing with OSCs but not studying the GM; (7) articles on other
diseases or plants or food or using other phytochemicals. The Boolean strings chosen were:
(onion* OR thiosulfinate OR thiosulfonate OR organosulfur) AND (gut* OR intestine* OR
bowel* OR gastrointestinal*) AND (microbiota* OR microflora* OR bacteria* OR micro-
biome* OR flora* OR bacterial* OR bacteria* OR microorganism* OR faeces* OR stool*).
The four comprehensive databases used were: Scopus, Web of Science, Science Database
and PubMed. The searches included works published in all languages. Scopus database
options search were: “title, abstract and keywords”. Web of Science database option search
was “theme” in all databases. Science Database and PubMed database option search was
“all fields”.
Two authors (PA-M and EG) formed the review team in order to implement measures
to minimize random errors and bias at all review stages and, separately, screened titles,
abstracts, and full texts of the works for potential inclusion. The 2 reviewers evaluated
them according to the eligibility criteria. Disagreements on whether a given reference
should be included were resolved through discussion between the review team. Once
the number of studies included for this systematic review was obtained, their quality
assessment started. It consisted of an assessment of the risks of bias of each of the studies,
following the model published in previous studies [10,13].
3. Results
3.1. Study Selection
The 530 works obtained by the 4 databases were crossed with the EndNote X9 software
to detect possible duplicated works. A total of 140 works were eliminated at this stage.
After reviewing the abstract of each of the remaining articles, those that were related to the
subject of the study (238) were selected. It is worthy of mentioning that some articles can
be included in more than one elimination group; however, the final criterion was agreed
upon by the review team.
Two additional articles were also found to be eligible from the bibliography section of
the 238 pre-selected works. Two extra articles not identified by the electronic databases
were added as the authors were aware of their existence. Finally, as shown in Figure 3,
a total of 17 articles [62–78] were found to be eligible for the present systematic review
following the full-text eligibility assessment. The characteristics of the selected articles are
summarized in Table 1. This table collects an overview of these articles, which includes the
type of Allium product used (OSCs or raw extract), the doses applied, evaluation model
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(in vitro or in vivo), the length of the study and the main findings related to their beneficial
effects in gut health (Table 1).
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Product Dose Model Time Main Findings
Roshan et al., 2017
[63] Onion juice Raw material C. difficile 24–48 h ↓ C. difficile
Roshan et al., 2018
[64]
Fresh onion
bulb extract Raw material
Toxin production by
C. difficile in Vero and
HT-29 cells
48 h ↓ Toxin production andactivity at 12.5%
Ruiz et al., 2010
[65] PTS




swine 24, 48, 72 h
↓ E. coli and S. typhimurium
= Lactobacillus and
Bifidobacterium
Zhai, et al., 2018
[66] Alliin 0.1 mg/mL C57BL/6J DIO
3 mice 8 weeks
↑ Actinobacteria and Firmicutes
↓ Bacteroidetes and
Proteobacteria





Product Dose Model Time Main Findings
Vezza et al., 2018
[67] PTSO
0.02–4.5 mg/L







↓ Firmicutes in the gut
contents
↓ Actinobacteria
Zhang et al., 2019
[68] Alliin 80 mg/kg Rats 14 days
↑ Firmicutes ↑ Allobaculum
↓ Bacteroidetes and Candidatus
Chen et al., 2019




Chen et al., 2020
[62] AFG
4 extract 10.000–50.000 mg/kg C57BL/6N mice 11 weeks
↓ F/B 5 en HFD 6 ↓ Dorea
↑ Lachnospiraceae
↑ Lactobacillus
Peinado et al., 2012
[70] PTSO 45–135 mg/kg broiler chickens 13 days ↓ Salmonella ↓ Campylobacter
Peinado et al., 2013
[71] PTSO 45–90 mg/kg Broiler chickens 21 days
↓ C. coccoides ↓ C. leptum
↑ Bacteroidetes in the ileal
contents
↓ Bacteroidetes in the cecal
contents
Rubio et al., 2015
[72] PTSO 45–90 mg/kg Broiler chickens 21 days
↑ Bacteroidetes
↓ Escherichia–Shigella
Ruiz et al., 2015
[73] PTSO 90 mg/kg Broiler chickens 21 days
↑ Bifidobacterium in ileal
mucosal
Abad et al., 2020




Sánchez et al., 2020
[75] Allium extract 5 g/kg
Growing-finishing
pigs 103 days
↓ Salmonella ↑ Lactobacillus in
faeces
↑ Levels of propionic,
isobutyric and isovaleric
acids in faeces
Satora et al., 2020






Rabelo et al., 2021a
[76] PTSO 60 mg/kg Laying hens 30 days
↑ Lactococcus in the ileum
↑ Lactobacillus in the cecum
Rabelo et al., 2021b
[77] Allium extract 20 mg/kg Piglets 42 days
↓ α-diversity in caecum and
colon
↑ Bacilli and ↓ Bacteroidia in
caecum
1 Propyl propane thiosulfinate (PTS); 2 Propyl propane thiosulfonate (PTSO); 3 diet induced obese (DIO); 4 Allicin-free garlic (AFG) extract;
5 Firmicutes/Bacteroidetes (F/B); 6 high-fat diet (HFD).
3.2. Evidence from In Vitro Assays
In this review, it was found that two articles tested Allium products in Clostridium
difficile populations [63,64]. The results showed how these products exerted a bactericidal
effect on different types of pathogenic bacteria. One article reported the in vitro efficacy
of one thiosulfonate in two human tumour cells [67]. This compound showed its role in
the anti-inflammatory response of both cell lines tested and the analysis of the results was
made through the analysis of relevant mediators in the pathogenesis of IBD. Another article
evaluated the in vitro influence of OSCs in GM of pigs, reporting the reduction of harmful
bacteria [65].
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3.3. Evidence from In Vivo Assays
Five of the selected articles reported results of assays conducted with Allium products
in murine models. Vezza et al. [67] investigated the effects of one onion-derived OSC in
two models with mice with colitis, which were able to modulate the GM composition of
the treated mice. Two articles studied how the consumption of an OSC derived from garlic
(alliin) influenced the GM in healthy rats [68], as well as in mice with obesity induced
by a high-fat diet (HFD) [66]. The results showed that, in both cases, the gut health of
the treated animals improved following changes in their GM populations. The other two
articles conducted in mice studied the effect of garlic extracts in mice with HFD-induced
dyslipidemia. Both articles reported optimal results in treated animals, achieving an
increase in beneficial bacteria of the GM [62,69]. Six articles of this systematic review
dealt with trials conducted in birds. A total of four of them were carried out with broiler
chickens [70–73] and two with laying hens [74,76]. In all cases, it was observed an increase
of certain beneficial bacteria and a decrease of harmful bacteria populations in the guts
of the evaluated animals. Three articles reported the influence of Allium products intake
in swine, showing beneficial effects such as the increase in beneficial bacteria [75,77] or
the reduction of pathogenic species [78] in the GM. All the assays conducted in birds and
swine models showed how the animals fed with diets supplemented with Allium products
had an improvement in their intestinal health, including an important antibacterial activity
against pathogenic species. Finally, no article was found dealing with clinical trials or
nutritional intervention studies in humans.
3.4. Risk of Bias
As discussed in Section 2, the risks of bias of each study were measured following
the model published in former studies [10]. Studies were considered to have a high (1–6),
medium (7–9) or low (10–12) risk of bias in terms of the consolidated score out of 12. A
low risk of bias was found in 14 articles selected in the present systematic review, and a
moderate risk was found in 3 articles. None of the selected articles showed a high risk
of bias. When assessing the quality of selection, the studies present more limitations in
comparability and in other bias items (controlled dietary intake, comorbidity, etc.). Full
details of scoring across the three types of bias are given in Table 2.



















2019 [69] 2 2 2 1 2 1 10 2 L
Peinado et al.,
2012 [70] 2 2 2 1 1 2 10 2 L
Peinado et al.,
2013 [71] 2 2 2 1 1 2 10 2 L
Rubio et al.,
2015 [72] 2 2 2 1 1 2 10 2 L
Ruiz et al.,
2015 [73] 2 2 2 1 1 2 10 2 L
Roshan et al.,
2017 [63] 2 1 2 1 1 2 9 3 M
Roshan et al.,
2018 [64] 2 1 2 1 1 2 9 3 M
Vezza et al.,
2019 [67] 2 2 2 2 1 2 11 1 L
Zhang et al.,
2019 [68] 2 2 2 1 2 2 11 1 L
Chen et al.,
2020 [62] 2 2 2 1 1 2 10 2 L




















2020 [75] 2 2 2 1 2 2 11 1 L
Zhai et al.,
2018 [66] 2 2 2 1 2 2 11 1 L
Ruiz et al.,
2010 [65] 2 1 1 1 1 2 8 4 M
Rabelo et al.,
2021a [76] 2 2 2 2 1 2 11 1 L
Rabelo et al.,
2021b [77] 2 2 2 2 1 2 11 1 L
Abad et al.,
2021 [74] 2 2 2 2 1 2 11 1 L
Satora et al.,
2020 [78] 2 2 2 2 1 2 11 1 L
Note: 0: not reported; 1: not appropriately or clearly evaluated; 2: appropriately evaluated. M: medium (7–9); L: low (10–12); H: high (6−1).
3.5. Limitations
The present systematic review was limited, by definition, by the databases used, the
Boolean strings chosen and the established criteria for inclusion or exclusion. In other
words, limitations related to search strategy and methodology. For instance, three of the
articles discussed [65,66,78] were not found by the four electronic databases used as they did
not contain the keywords of the Boolean string chosen in their title, abstract, or keywords
sections. However, the search strategy was deeply exhaustive, thus it was expected that
only relatively few relevant studies were not identified. Only works reported in English
were included and this fact could suggest bias in the search, as reported elsewhere [79,80].
In addition, the fact that 17 articles were finally included could suggest bias in the eligibility
strategy as the final sample of selected articles could be not representative [79]. Finally, the
lack of sufficient statistical information reported in the selected articles made it impossible
to combine the results of different studies in a meta-analysis.
4. Discussion
The present systematic review aims to discuss 17 articles that have studied the rela-
tionship between the consumption of Allium products, intestinal health and GM. This work
is focused on the influence of the OSCs present in Allium species, although there are also
some studies that describe beneficial effects on GM of non-sulfur compounds present in the
genus Allium. For example, the oral administration of quercetin together with resveratrol
was able to restore the dysbiosis of the GM induced by HFD in Wistar rats [81]. The results
demonstrated that the treatment could modulate the GM of rats, decreasing the population
of Firmicutes and inhibiting the relative abundance of obesity-related families such as
Coriobacteriaceae, Lachnospiraceae, Acidaminococcaceae, Desulfovibrionaceae and Bilophila. In
another recent study, dietary supplementation with a polysaccharide from Jinxiang garlic
alleviated colitis in mice. The treated animals showed an improvement in the structure of
the intestinal mucosa, and, in addition, the blocking of certain pro-inflammatory cytokines
was observed [82]. We have not found any other systematic review linking OSCs to gut
health or GM, except a systematic review and meta-analysis that evaluated solely the use of
allicin as a complementary therapy for H. pylori infection and whose efficacy was evaluated
in randomized controlled trials [83].
Beyond allicin, other OSCs from Allium have shown antibacterial activity against
Gram-positive and Gram-negative bacteria, including species of the genera Escherichia,
Salmonella, Bacteroidetes, Klebsiella, Streptococcus, Neisseria, Proteus, Clostridium, Mycobac-
terium, Staphylococcus, Micrococcus and Bacillus [52]. Specifically, thiosulfinates and thiosul-
fonates have significant antimicrobial activity against Escherichia, Salmonella, Clostridium,
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Campylobacter and Aspergillus species [70], and also even against numerous strains of
antibiotic-resistant bacteria isolated from human clinical samples [52].
OSCs from Allium have also shown antibacterial effects against other bacteria associ-
ated with severe gastrointestinal symptoms such as C. difficile. This bacterium can cause
symptoms ranging from diarrhoea to life-threatening inflammation of the colon. Toxins are
the main virulence factor that initiates C. difficile infection (CDI), causing inflammation and
damaging the lining of the intestine. CDI most often affects older adults with long-term
healthcare treatment and usually occurs after using antibiotics. For this reason, it could
be important to find alternatives to antibiotics for the prevention and treatment of this
disorder [63,64]. In a first study conducted by Roshan et al. [63], several natural products
were tested against C. difficile, with the highest activity exerted by the juice extracted from
fresh garlic cloves. The great advantage of using OSCs from Allium against CDI is that these
compounds have a bactericidal effect against C. difficile at lower concentrations than those
that affect beneficial bacteria such as Lactobacillus species. In a later study conducted by the
same researcher team [64], fresh onion extract showed a reduction not only in C. difficile
but also in the production of its pathogenic toxins, both in Vero (monkey kidney cells) and
in HT-29 (human colorectal adenocarcinoma cells) cell lines.
Another species of the same genus, Clostridium perfringens, is part of the normal GM
of livestock animals, mainly in poultry species such as broilers or turkeys. This bacterium
grows under anaerobic conditions and produces toxic spores highly resistant to drying, heat,
acids and other harsh environmental factors. Under normal health conditions, beneficial
bacteria in the gut keep C. perfringens counts small in numbers, thus that it does not cause
any disease in animals. However, when conditions change in the GT, the population of this
bacteria increases, and the production of toxins may lead to the appearance of intestinal
irritation and a disease known as necrotic enteritis, which severely affects the poultry
industry [84]. The banning of the use of antibiotic growth promoters (AGP) in animal
feed resurfaced this issue, increasing the number of flocks affected and, consequently, the
economic losses [85]. Therefore, the inclusion of antimicrobial phytochemicals such as
OSCs into feed has become a useful approach to reduce pathogenic bacteria populations in
the GM and the reduction of losses caused by the aforementioned disease [86].
The antimicrobial activity of Allium extracts containing PTS and PTSO has also been
evaluated in an in vitro assay conducted by Ruiz et al. with GM of sows [65]. The results
showed significant antibacterial activity of both compounds against all the studied groups,
being Enterobacteriaceae the most sensitive species. In addition, the same authors carried out
the kill curves of PTS and PTSO against E. coli and Salmonella typhimurium, two common
enteropathogens in swine production. Both OSCs exerted a rapid bactericidal effect in a
dose-dependent manner. On the contrary, Lactobacillus and Bifidobacterium were the most
resistant populations to these compounds. In line with these results, other articles reported
the antibacterial activity of PTS and, especially, PTSO, against Gram-positive and Gram-
negative human clinical isolates [52,87]. The results highlighted the special sensitivity of
E. coli or Salmonella strains, regardless of their resistance to antibiotics such as cefotaxime or
cefazidime, or their capacity to produce Extended-Spectrum Beta-Lactamase. Moreover, the
activity against Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus,
Enterococcus faecalis and Streptococcus agalactiae was higher than the one observed against
enterobacteria, especially in the case of PTSO [52,87].
There is much evidence that the condition of the gut microbiome is deeply involved
in animal and human health status. Bacterial species belonging to the Lactobacillus and
Bifidobacterium genera are generally considered beneficial, while the increase of Clostridum,
Eubacterium or Bacteroidetes, is considered harmful to health [88,89]. Variations in the
composition and function of the GM lead to a decrease in microbial diversity and the
expansion of certain bacterial groups usually considered as harmful, which is related to the
development of many diseases [88–91].
In two studies carry out in mice with dyslipidemia induced by HFD, the admin-
istration of Allium products derived from garlic showed an attenuation of the harmful
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effects caused by this diet on GM [62,69]. In one of these assays, whole garlic was admin-
istered [69], while, in the other one, the Allium product tested was an allicin-free garlic
extract (AFG) [62]. In both assays, diets supplemented with garlic positively impacted GM,
as supplementation succeeded in restoring the number of beneficial bacteria to the gut
health of mice, such as Lachnospiraceae and Akkermansia, whose counts had been reduced
by HFD. The administration of AFG extract was able to reduce the increase in the F/B ratio
caused by HFD, relieving the negative impact of this diet on the health of animals and
their inflammatory response [62]. The mice that consumed whole garlic in the latter study,
showed a greater regulation of the diversity of GM, which led to revert the reduction of
Bacteroidetes and beneficial species of the genus Prevotella caused by HFD [69].
In another study conducted in mice with obesity induced by HFD, the effect of
consuming alliin was evaluated in order to demonstrate the preventive effect of this
compound against the metabolic risk factors associated with obesity [66]. The results
showed an improvement in glucose homeostasis and lipid profile in the animals whose
diet was supplemented with alliin. The mechanism for the hypoglycemic effect of this
compound is not clear, though it might be partially attributed to the modulating effect
of alliin on the composition of GM, and, in particular, to the increase of Ruminococcaceae,
which seems to inhibit the negative effects caused by HFDs. Beyond Ruminococcaceae, mice
fed with supplemented diet experienced an increase in other classes of Firmicutes and
also Actinobacteria, along with a reduction in the number of Bacteroidetes and Proteobacteria,
though these results did not reach a significant level [66]. Similar findings were obtained
in another study conducted with alliin in healthy rats [68]. The group that took alliin
presented a higher abundance of Firmicutes and a lower abundance of Bacteroidetes than the
control group, although the differences were not statistically significant [68].
Vezza et al. [67] tested the activity of PTSO in two experimental models of mice with
colitis. Microbial richness and evenness were significantly decreased in the colitic group
compared to the non-colitic one, being both ecological parameters restored in colitic mice
treated with PTSO. In particular, the composition of GM at the phylum level showed a
significantly higher abundance of Firmicutes and a lower level of Bacteriodetes in the colitic
control group when compared with non-colitic mice. Oral administration of PTSO to colitic
mice was able to ameliorate these changes, having a decrease of Firmicutes abundance in the
gut of the mice that led to a reduction in the F/B ratio. On the contrary, although the level
of Bacteriodetes was not significantly modified, the abundance of Actinobacteria increased in
the PTSO-treated colitic mice compared to the control group. The authors concluded that
the administration of PTSO to colitic mice was able to restore the parameters in the colitic
models without showing statistical differences with non-colitic mice [67].
The rising global restrictions in the use of AGP worldwide have increased the need
to apply new antibacterial or prebiotic ingredients for feed. Among these ingredients,
phytochemicals stand out for their antimicrobial activity and their ability to modulate
GM [92–94]. In particular, there are several references about the benefits of the inclusion of
secondary metabolites from Allium species in the diet of animals. Among these benefits, it
can be highlighted the improvement of intestinal health, the modulation of the inflamma-
tory response and the improvement in the absorption of nutrients, which, consequently,
speeds the growth of animals [92,95–97].
There is much evidence that the state of GM in poultry and swine contributes to their
health and productivity [98,99]. The influence of the microbiome is particularly relevant in
young animals since the composition of their GM is still under development [16]. According
to Rubio et al. [72], Bacteroidetes family is involved in important metabolic activities in
broilers, including the metabolism of carbohydrates and nitrogenous substances, as well as
the prevention of the colonization of pathogens such as Salmonella, Campylobacter jejuni and
C. perfringens. Other families involved in the composition of the cecal microbiota of broilers
are Lachnospiraceae, Ruminococcaceae and Micrococcaceae [72]. Nevertheless, GM of swine is
dominated by Firmicutes, followed by Proteobacteria in the large intestine and Bacteroidetes
in the small intestine [100].
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It has been reported that supplementation with Allium hookeri leaves produced mod-
ulation of GM in broilers [101]. In addition, the addition of onion powder to the diet of
broilers caused a significant reduction in E. coli population and the increase of Lactobacillus
and Streptococcus species, achieving an improvement in the gut histomorphology [96].
However, most of the research on the effects of OSCs on GM of birds has been conducted
with the use of specific secondary metabolites from onion, as PTSO. For example, Ruiz
et al. [65] reported that PTSO is able to modulate the GM composition associated with
the ileal mucosa of Bifidobacterium species and the Blautia coccoides/Eubacterium rectole
bacterial group of broiler chickens. Other positive data from this study were the increase
of certain species of Bifidobacterium in the gut, such as B. pseudolongum, B. longum and
B. pseudocatenulatum. In another recent article [74], the use of an onion extract containing
PTSO was also able to modify GM of laying hens, reducing the number of Enterobacteriaceae,
Lactobacillus and Bifidobaterium in faeces after one week of supplementation. In two studies
conducted with broilers [70,71], the administration of an Allium product containing PTS
and PTSO improved the gut health of the treated animals. In one of these assays, PTS
and PTSO showed antimicrobial activity against different bacterial groups, reducing the
fecal counts of Enterobacteriaceae and coliforms [70]. In the second study referred, PTSO
supplementation modulated the GM composition in broiler chickens and also improved
the nutrient digestibility without affecting activity of mucosal enzymes [71]. Similar results
were obtained in another assay with broilers [82], where a significant bactericidal effect of
PTSO against enterobacteria, coliforms, E. coli, C. jejuni and Salmonella, both in vitro and
in vivo, was revealed.
Results showing the benefits of OSCs have also been reported in experiments in swine.
Sanchez et al. [75] have shown that the inclusion of PTSO in the growing-finishing pig diet
was beneficial for their GM. The authors found a significant increase of Lactobacillus and
a reduction in the counts of coliforms and enteropathogens (Salmonella and Clostridium)
in faeces, compared to those animals that consumed a basal diet that included antibiotics
but not PTSO. The analysis of microbiome in sows, reported in another recent article [78],
showed the reduction of intestinal pathogenic species in those animals that ingested an
extract composed of garlic and probiotics, compared to the control group. Moreover, in
another assay conducted in swine [65], another extract containing PTS and PTSO was used
as a feed additive. The results revealed an improvement in the intestinal health of the
treated animals, increasing the digestibility of the nutrients.
Taking into account the results mentioned above, it could be concluded that PTSO,
when added to the diet of the animals, is capable of reducing certain GM bacterial popula-
tions in a dose-dependent manner, being enterobacteria and coliforms the most affected.
In another and more recent article, the effect of the intake of an onion and garlic extract
including PTS and PTSO was evaluated on the GM of piglets [77]. In this trial, the bacteria
diversity in different intestinal regions was analyzed. These data were compared to the gut
composition of a group of piglets whose diet was supplemented with antibiotics (colistin
and zinc oxide) and another control group. The microbiome of piglets belonging to the
Allium group and the control group were very similar. On the contrary, the GM of piglets
belonging to the antibiotic group showed a lower proportion of bacilli and a higher propor-
tion of Clostridia and Bacteroidia. More specifically, the number of Lactobacillus decreased
in these animals, especially in the colon, while the genus Prevotella increased [77].
Further experiments are necessary to deepen our understanding of the interactions
between GM and the host, as well as the mechanisms of action involved. Future studies
should try to homogenize, as far as possible, the characteristics of samples to be compared
and the methods for detecting bacterial populations. However, given the numerous pieces
of evidences discussed, both in vitro and in experimental models, the benefits for GM of
treatments with OSCs seem clear. However, it would be interesting to perform dietary
interventional assays with these products in humans since none has been made until the
date with compounds derived from onion such as PTS or PTSO.
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5. Conclusions
This is the first systematic review about the benefits on the GM and intestinal health by
Allium products, specifically by secondary metabolites from onion. A total of 530 publications
were found from the four different electronic databases used. This number was reduced to
thirteen after removing duplicate publications and the application of the inclusion/exclusion
criteria established by the reviewer team. In addition, two articles were also found to be
eligible from the bibliography section of the pre-selected works, and two extra articles,
not identified by the electronic databases, were added as the authors were aware of their
existence. Taking into account all of the aforementioned, 17 original articles were included
in this systematic review to describe the current scientific evidence of the modulating effect
on GM exerted by Allium products and, in particular, by OSCs from Allium cepa. These
compounds showed significant antibacterial activity against a broad spectrum of enteric
pathogens, both in vitro and in vivo, including antibiotic-resistant bacteria isolated from
clinical specimens. Numerous in vivo assays, conducted with different animal models,
reported that the intake of OSCs from onion was able to modulate the composition of GM,
increasing the beneficial bacterial populations. Moreover, the effects of these compounds in
murine models with colitis and obesity suggested that they could be suitable candidates for
the treatment of IBD or reverse the alteration of GM caused by HFDs. Despite the evidence
found in different animal models, no article has been found reporting the effects of other
OSCs, apart from allicin, in clinical trials or dietary interventions in humans. In this sense,
it would be interesting to conduct new research to test the benefits of these compounds in
human GM.
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